-Search query
-Search result
Showing 1 - 50 of 6,342 items for (author: ren & g)
EMDB-37414:
Structure of PSII-ACPII supercomplex from cryptophyte algae
Method: single particle / : Li XY, Mao ZY, Shen JR, Han GY
EMDB-38419:
Structure of ACPII-CCPII from cryptophyte algae
Method: single particle / : Li XY, Mao ZY, Shen JR, Han GY
PDB-8wb4:
Structure of PSII-ACPII supercomplex from cryptophyte algae
Method: single particle / : Li XY, Mao ZY, Shen JR, Han GY
PDB-8xkl:
Structure of ACPII-CCPII from cryptophyte algae
Method: single particle / : Li XY, Mao ZY, Shen JR, Han GY
EMDB-36960:
F8-A22-E4 complex of MPXV in complex with DNA and Ara-CTP
Method: single particle / : Shen YP, Li YN, Yan RH
EMDB-36962:
F8-A22-E4 complex of MPXV in complex with DNA and dCTP
Method: single particle / : Shen YP, Li YN, Yan RH
EMDB-36963:
the local map of DNA and Ara-CTP binding site
Method: single particle / : Shen YP, Li YN, Yan RH
EMDB-36964:
the local map of DNA and dCTP binding site
Method: single particle / : Shen YP, Li YN, Yan RH
PDB-8k8s:
F8-A22-E4 complex of MPXV in complex with DNA and Ara-CTP
Method: single particle / : Shen YP, Li YN, Yan RH
PDB-8k8u:
F8-A22-E4 complex of MPXV in complex with DNA and dCTP
Method: single particle / : Shen YP, Li YN, Yan RH
EMDB-19014:
PDCoV spike glycoprotein ectodomain in complex with the 22C10 antibody Fab fragment
Method: single particle / : Debski-Antoniak O, Drulyte I, Hurdiss DL
EMDB-19015:
Local refinement of the PDCoV spike glycoprotein ectodomain in complex with the 22C10 antibody Fab fragment
Method: single particle / : Debski-Antoniak O, Hurdiss DL
EMDB-19016:
S1B domain of the PDCoV spike glycoprotein in complex with the 67B12 and 42H3 antibody Fab fragments
Method: single particle / : Debski-Antoniak O, Hurdiss DL
EMDB-19017:
S1B domain of the PDCoV spike glycoprotein in complex with the 67B12 and 46E6 antibody Fab fragments
Method: single particle / : Debski-Antoniak O, Drulyte I, Hurdiss DL
EMDB-19986:
Structure of recombinant alpha-synuclein fibrils 1B capable of seeding GCIs in vivo
Method: helical / : Burger D, Kashyrina M, Lewis A, De Nuccio F, Mohammed I, de La Seigliere H, van den Heuvel L, Feuillie C, Verchere J, Berbon M, Arotcarena M, Retailleau A, Bezard E, Laferriere F, Loquet A, Bousset L, Baron T, Lofrumento DD, De Giorgi F, Stahlberg H, Ichas F
PDB-9euu:
Structure of recombinant alpha-synuclein fibrils 1B capable of seeding GCIs in vivo
Method: helical / : Burger D, Kashyrina M, Lewis A, De Nuccio F, Mohammed I, de La Seigliere H, van den Heuvel L, Feuillie C, Verchere J, Berbon M, Arotcarena M, Retailleau A, Bezard E, Laferriere F, Loquet A, Bousset L, Baron T, Lofrumento DD, De Giorgi F, Stahlberg H, Ichas F
EMDB-42837:
Cryo-EM structure of GeoCas9 in complex with sgRNA and target DNA
Method: single particle / : Eggers AR, Soczek KM, Tuck OT, Doudna JA
EMDB-42838:
Cryo-EM structure of iGeoCas9 in complex with sgRNA and target DNA
Method: single particle / : Eggers AR, Soczek KM, Tuck OT, Doudna JA
PDB-8uza:
Cryo-EM structure of GeoCas9 in complex with sgRNA and target DNA
Method: single particle / : Eggers AR, Soczek KM, Tuck OT, Doudna JA
PDB-8uzb:
Cryo-EM structure of iGeoCas9 in complex with sgRNA and target DNA
Method: single particle / : Eggers AR, Soczek KM, Tuck OT, Doudna JA
EMDB-40815:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies C3V5, V1V3, N611 and base from participant 017
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB
EMDB-40816:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies gp41-N611/FP and base from participant 03
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB
EMDB-40817:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies gp41-N611/FP and base from participant 07
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB
EMDB-40818:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies gp120-GH and base from participant 09
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB
EMDB-40819:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies C3V5, V1V3, gp41-GH/FP and base from participant 11
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB
EMDB-19426:
Escherichia coli 50S subunit in complex with the antimicrobial peptide Api137
Method: single particle / : Lauer S, Nikolay R, Spahn C
EMDB-19427:
Escherichia coli 50S subunit in complex with the antimicrobial peptide Api88 - conformation I
Method: single particle / : Lauer S, Nikolay R, Spahn C
EMDB-19428:
Escherichia coli 50S subunit in complex with the antimicrobial peptide Api88 - conformation II
Method: single particle / : Lauer S, Nikolay R, Spahn C
EMDB-19429:
Escherichia coli 50S subunit in complex with the antimicrobial peptide Api88 - conformation III
Method: single particle / : Lauer S, Nikolay R, Spahn C
PDB-8rpy:
Escherichia coli 50S subunit in complex with the antimicrobial peptide Api137
Method: single particle / : Lauer S, Nikolay R, Spahn C
PDB-8rpz:
Escherichia coli 50S subunit in complex with the antimicrobial peptide Api88 - conformation I
Method: single particle / : Lauer S, Nikolay R, Spahn C
PDB-8rq0:
Escherichia coli 50S subunit in complex with the antimicrobial peptide Api88 - conformation II
Method: single particle / : Lauer S, Nikolay R, Spahn C
PDB-8rq2:
Escherichia coli 50S subunit in complex with the antimicrobial peptide Api88 - conformation III
Method: single particle / : Lauer S, Nikolay R, Spahn C
EMDB-41514:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-1 week 0
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41515:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-1 at week 4
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41516:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-1 at week 16
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41517:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-1 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41518:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-2 at week 0
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41519:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 2-1 at week 4
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41520:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-2 at week 16
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41521:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-2 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41522:
Polyclonal immune complex of fab binding the H2 HA from serum of subject 1-3 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41541:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 3-3 at week 0
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41543:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 3-3 at week 16
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41544:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 3-3 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41545:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-1 at week 0
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41546:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-1 at week 4
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41547:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-1 at week 16
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41548:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-1 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41549:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-2 at week 0
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
Pages: